118th Congress Health
S. 2454: Pharmaceutical Supply Chain Security Act
Introduced
- Introduced (completed)
- Passed Senate (not reached)
- Passed House (not reached)
- To the President (not reached)
- Became law (not reached)
Summary
This bill directs certain agencies to report on and reduce the role of China in pharmaceutical supply chains.
Specifically, the Food and Drug Administration must report on pharmaceutical products and ingredients for which China supplies more than 20% of the quantities available in the United States. In addition, the President must develop a strategy to address the role of China in the global pharmaceutical supply chain and related threats to national security. The United States International Development Finance Corporation must also support manufacturing projects that promote the security of pharmaceutical supply chains, reduce reliance on China, and foster cooperation with other countries.
Written by the Congressional Research Service, Library of Congress.
Roll calls
No roll call votes have been held on this bill.
Amendments
No amendments were offered to this bill.
Cosponsors
- Gary Peters D-MI
Who scored on this bill
- 1James Lankford SponsorIntroduced, drew cross-party cosponsors2 events+6
See all scorers and every scoring event
Introductions and cosponsorships count toward weekly caps and show no points.
Other bills by James Lankford
- S. 3175: CIPZIP Act of 2025
- S. 1051: Historic Greenwood District—Black Wall Street National Monument Establishment Act
- S. 2283: Oscar J. Upham Post Office (Guthrie, OK)
- S. 81: Guidance Clarity Act of 2025
- S. 5098: Taxpayer Resources Used in Emergencies Accountability Act
- S. 5314: To designate the medical center of the Department of Veterans Affairs in Tulsa, Oklahoma, as the James Mountain Inhofe VA Medical Center
History
- Introduced in the Senate by James Lankford.
Show the full action history (2 actions)
- Introduced in Senate
- Read twice and referred to the Committee on Foreign Relations.